Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
1. 系统已在2026-05-20 10:54:04对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.medj.2026.101029
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2666634026000322
其他信息:
出版社: Elsevier BV
作者: Fei Han; Xing Lv; Yu-Juan Zhou; Qian He; Ye Guo; Yan-Qun Xiang; Xiao-Lei Shu; Su-Ming Pan; Shen-Hong Qu; Peng Zhang; Yi Jiang; Ming-Jun Xu; Kai-Jian Lei; Song Qu; Xiao-Hui Wang; Yong-Shuai Jin; Bei Zhao; Rui Dai; Feng-Hua Wang; Rui-Hua Xu

